BAP1 and nonpapillary renal cell carcinoma: BAP-1 mutations, which have been associated with poor prognosis in ccRCC (34, 35), were observed in 10% of tumors in the overall cohort, consistent with prior studies (16, 36–38), and no differential expression was seen between the primary renal tumors versus sites of metastasis.